期刊文献+

核心指标集研究方案的标准报告条目解读及不同核心指标集研究报告指南对中医药领域研究的意义 被引量:8

The comparison of research and reporting guideline for core outcome sets and the significance for research in traditional Chinese medicine
原文传递
导出
摘要 自有效性试验核心结局指标测量(Core Outcome Measures in Effectiveness Trials,COMET)工作组成立以来,相继发布了一系列核心指标集相关的研究及报告指南。本文对COMET工作组于2019年2月发布的核心指标集研究方案的标准报告条目[COS-STAP声明,(Core Outcome Set-STAndardised Protocol Items:the COS-STAP Statement)]进行介绍和解读,并与之前已介绍到的国内的核心指标集报告规范(Core Outcome Set-STAndards for Reporting,COS-STAR)、核心指标集研究标准(Core Outcome Set-STAndards for Development,COS-STAD)进行比较,讨论不同核心指标集研究报告指南对中医药领域核心指标集构建的意义,为以后的研究提供思路和借鉴。 The Core Outcome Measures in Effectiveness Trials(COMET) Working Group has published a series of research and reporting guidelines related to core outcome sets since it was established. This article introduces and interprets the Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement which is developed by the COMET and published in February 2019. It will then be compared with Core Outcome Set-STAndards for Reporting(COS-STAR) and Core Outcome Set-STAndards for Development(COS-STAD), which have been introduced to China.The significance of these guidelines for the development of core outcomes in the field of traditional Chinese medicine is discussed, so as tp draw researchers’ attention to this area.
作者 邱瑞瑾 胡嘉元 李敏 钟长鸣 关曼柯 黄涯 韩松洁 何天麦 陈静 商洪才 QIU Ruijin;HU Jiayuan;LI Min;ZHONG Changming;GUAN Manke;HUANG Ya;HAN Songjie;HE Tianmai;CHEN Jing;SHANG Hongcai(Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital,Beijing University of Chinese Medicine,Beijing,100700,P.R.China;Baokang Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,300193,P.R.China)
出处 《中国循证医学杂志》 CSCD 北大核心 2019年第12期1492-1497,共6页 Chinese Journal of Evidence-based Medicine
基金 国家自然科学基金项目(编号:81430098) 第二批国家“万人计划”科技创新领军人才特殊支持经费资助(编号:W02020052) 中央高校基本科研业务费专项资金资助(编号:2019-JYB-JS-033)
关键词 核心指标集 中医药 COS-STAP声明 COS-STAR COS-STAD 方法学 Core outcome sets Traditional Chinese medicine Core Outcome Set-STAndardised Protocol Items(COS-STAP) Core Outcome Set-STAndards for Reporting(COS-STAR) Core Outcome Set-STAndards for Development(COS-STAD) Methodology
  • 相关文献

参考文献8

二级参考文献44

  • 1王永炎,张启明,张志斌.证候要素及其靶位的提取[J].山东中医药大学学报,2006,30(1):6-7. 被引量:159
  • 2毛兵,王刚,陈小东,樊涛,刘佳,王蕾,常静,张颖,郭佳,李廷谦.《中国中西医结合杂志》发表随机对照试验报告的质量评价[J].中国循证医学杂志,2006,6(4):297-304. 被引量:37
  • 3Sinha I P,GaUagher R,Williamson P R,et al.Development of a core outcome set for clinical trials in childhood asthma:a survey of clinicians,parents,and young people.Trials,2012,13:103. 被引量:1
  • 4Kirwan J R,Hewlett S E,Heiberg T,et al.Incorporating the patient perspective into outcome assessment in rheumatoid arthritis:progress at OMERACT 7.J Rheumatol,2005,32(11): 2250-2256. 被引量:1
  • 5Gandhi G Y,Murad M H,Fujiyoshi A,et al.Patient-important outcomes in registered diabetes trials.JAMA,2008,299(21):2543- 2549. 被引量:1
  • 6Sinha I P,Williamson P R,Smyth R L.Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focused on short term disease activity.PLoS ONE,2009,4(7):e6276. 被引量:1
  • 7World Health Organization.WHO Handbook for Reporting Results of Cancer Treatment.In WHO Offset publication No 48 Geneva:WHO, 1979. 被引量:1
  • 8Miller A B,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment,Cancer, 1981,47(1):207-214. 被引量:1
  • 9Tugwell P,Boers M.OMERACT conference on outcome measures in rheumatoid arthritis clinical trials:Introduction.J Rheumatol, 1993,20(3):528-530. 被引量:1
  • 10Tugwell P,Boers M,Brooks P,et aI.OMERACT:an international initiative to improve outcome measurement in rheumatology. Trials,2007,8:38. 被引量:1

共引文献173

同被引文献129

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部